Nomogram for the prediction of diabetic nephropathy risk among patients with type 2 diabetes mellitus based on a questionnaire and biochemical indicators: a retrospective study

被引:34
|
作者
Hu, Yuhong [1 ]
Shi, Rong [1 ]
Mo, Ruohui [1 ]
Hu, Fan [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Sch Publ Hlth, Shanghai, Peoples R China
来源
AGING-US | 2020年 / 12卷 / 11期
关键词
diabetic nephropathy; predictors; nomogram; type 2 diabetes mellitus; risk factors; CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; BLOOD-PRESSURE CONTROL; GLOMERULAR HYPERFILTRATION; RENAL-DISEASE; FOLLOW-UP; MICROVASCULAR COMPLICATIONS; GLUCOSE CONTROL; UNITED-STATES; PREVALENCE;
D O I
10.18632/aging.103259
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Purpose: Develop a diabetic nephropathy incidence risk nomogram in a Chinese population with type 2 diabetes mellitus. Results: Predictors included systolic blood pressure, diastolic blood pressure, fasting blood glucose, glycosylated hemoglobin A1c, total triglycerides, serum creatinine, blood urea nitrogen and body mass index. The model displayed medium predictive power with a C-index of 0.744 and an area under curve of 0.744. Internal verification of C-index reached 0.737. The decision curve analysis showed the risk threshold was 20%. The value of net reclassification improvement and integrated discrimination improvement were 0.131, 0.05, and that the nomogram could be applied in clinical practice. Conclusion: Diabetic nephropathy incidence risk nomogram incorporating 8 features is useful to predict diabetic nephropathy incidence risk in type 2 diabetes mellitus patients. Methods: Questionnaires, physical examinations and biochemical tests were performed on 3489 T2DM patients in six communities in Shanghai. LASSO regression was used to optimize feature selection by running cyclic coordinate descent. Logistic regression analysis was applied to build a prediction model incorporating the selected features. The C-index, calibration plot, curve analysis, forest plot, net reclassification improvement, integrated discrimination improvement and internal validation were used to validate the discrimination, calibration and clinical usefulness of the model.
引用
收藏
页码:10317 / 10336
页数:20
相关论文
共 50 条
  • [41] Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus
    Bakris, George L.
    MAYO CLINIC PROCEEDINGS, 2011, 86 (05) : 444 - 456
  • [42] Risk prediction of nephropathy by integrating clinical and genetic information among adult patients with type 2 diabetes
    Liao, Li-Na
    Li, Tsai-Chung
    Yeh, Chih-Ching
    Li, Chia-Ing
    Liu, Chiu-Shong
    Yang, Chuan-Wei
    Yang, Ya-Fei
    Lin, Chih-Hsueh
    Tsai, Fuu-Jen
    Lin, Cheng-Chieh
    ACTA DIABETOLOGICA, 2023, 60 (03) : 413 - 424
  • [43] Comparison of Machine Learning Algorithms and Nomogram Construction for Diabetic Retinopathy Prediction in Type 2 Diabetes Mellitus Patients
    Jiang, Weiliang
    Li, Zijing
    OPHTHALMIC RESEARCH, 2024, 67 (01) : 537 - 548
  • [44] Analysis of risk factors for progression of diabetic nephropathy in patients with type 2 diabetes
    Kovacevic, Marijana
    Kovacevic, Maksim
    Prodanovic, Verica
    Cancar, Olivera
    Malis, Snezana
    Cancar, Vladimir
    Dukanovic, Ljubica
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2021, 149 (5-6) : 295 - 300
  • [45] Prevalence of Diabetic Nephropathy among Patients with Type 2 Diabetes Mellitus in China: A Meta-Analysis of Observational Studies
    Zhang, Xin-Xin
    Kong, Jun
    Yun, Ke
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [46] Development and validation of a nomogram model for individualized prediction of hypertension risk in patients with type 2 diabetes mellitus
    Yang, Jing
    Wang, Xuan
    Jiang, Sheng
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [47] Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: A clinic-based retrospective longitudinal study
    Kajiwara, A.
    Miyagawa, H.
    Saruwatari, J.
    Kita, A.
    Sakata, M.
    Kawata, Y.
    Oniki, K.
    Yoshida, A.
    Jinnouchi, H.
    Nakagawa, K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (03) : E7 - E10
  • [48] Haptoglobin genotype and risk of diabetic nephropathy in patients with type 1 diabetes mellitus: a study on a Spanish population
    Amor, Antonio J.
    Canivell, Silvia
    Oriola, Josep
    Ricart, Maria J.
    de Hollanda, Ana M.
    Bosch-Comas, Anna
    Esmatjes, Enric
    NEFROLOGIA, 2014, 34 (02): : 212 - 215
  • [49] Predicting medication nonadherence risk in the Chinese type 2 diabetes mellitus population - establishment of a new risk nomogram model: a retrospective study
    Wang, Fa-Cai
    Chang, Wei
    Nie, Song-Liu
    Shen, Bing-Xiang
    He, Chun-Yuan
    Zhao, Wei-Chen
    Liu, Xiao-Yan
    Lu, Jing-Tao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (09)
  • [50] Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy
    Palazhy, Sabitha
    Viswanathan, Vijay
    DIABETES & METABOLISM JOURNAL, 2017, 41 (02) : 128 - 134